How CEO Anne Wojcicki Turned 23andMe Around After Falling Out With The FDA


Here’s how 23andMe matured as a company and got back in the FDA’s good gracesafter its genetic health tests were shut down two years ago.

“Silicon Valley is built on impatience and doing things rapidly,” says Anne Wojcicki, the CEO of direct-to-consumer genetic testing company 23andMe. “But what I had to learn is that not everything comes overnight. Sometimes we just have to wait and, if you focus on the positives, that can be just as rewarding.”
Source: How CEO Anne Wojcicki Turned 23andMe Around After Falling Out With The FDA